✦ LIBER ✦

Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma

✍ Scribed by S. John Weroha; Ann L. Oberg; Katie L. Allen Ziegler; Shaker R. Dakhilm; Kendrith M. Rowland; Lynn C. Hartmann; Dennis F. Moore Jr.; Gary L. Keeney; Prema P. Peethambaram; Paul Haluska

Book ID: 113963184
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 240 KB
Volume: 122
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.03.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II prospective study of weekly top

Phase II prospective study of weekly topotecan and bevacizumab in platinum refractory ovarian or primary peritoneal cancer (OC)

✍ K.F. McGonigle; H.G. Muntz; J. Vuky; P.J. Paley; D.S. Veljovich; H.J. Gray; T.W. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Phase II clinical trial of bevacizumab w

Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma

✍ Tillmanns, Todd D.; Lowe, M. Patrick; Walker, Mark S.; Stepanski, Edward J.; Sch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Phase 2 trial of prolonged administratio

Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancers

✍ Maurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peters 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase II trial of imatinib mesylate in p

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers

✍ Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A phase I/II trial of weekly topotecan a

A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma

✍ Peter G. Rose; Mary Smrekar; Pamela Haba; Christina Visser; John F. Beeler 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Topotecan in patients with BRCA-associat

Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers

✍ David M. Hyman; Qin Zhou; Angela G. Arnold; Rachel N. Grisham; Alexia Iasonos; N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB